25D-NBOMe

From Wikipedia, the free encyclopedia
Jump to: navigation, search
25D-NBOMe
25D-NBOMe2DACS.svg
Systematic (IUPAC) name
2-(2,5-dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine
Clinical data
Legal status
?
Identifiers
CAS number 1354632-02-2
ATC code ?
Chemical data
Formula C19H25NO3 
Mol. mass 315.41 g/mol

25D-NBOMe (or NBOMe-2C-D) is a derivative of the phenethylamine derived hallucinogen 2C-D. It acts in a similar manner to related compounds such as 25I-NBOMe, which is a potent agonist at the 5HT2A receptor.[1][2] 25D-NBOMe has been sold as a street drug since 2010 and produces similar effects in humans to related compounds such as 25I-NBOMe and 25C-NBOMe.[3] It was banned as a Temporary Class Drug in the UK on 10 June 2013 after concerns about its recreational use.[4]

Legal status and scheduling[edit]

Sweden[edit]

Sveriges riksdag added 25D-NBOMe to schedule I ("substances, plant materials and fungi which normally do not have medical use") as narcotics in Sweden as of Aug 1, 2013, published by Medical Products Agency in their regulation LVFS 2013:15 listed as 25D-NBOMe 2-(2,5-dimetoxi-4-metylfenyl)-N-(2-metoxibensyl)etanamin.[5]

See also[edit]

References[edit]